查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378874

骨质疏鬆症药物市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Osteoporosis Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球骨质疏鬆药物市场规模达到158亿美元。展望未来， IMARC Group预计到2028年市场规模将达到210亿美元，2022-2028年复合年增长率（CAGR）为4.9%。

骨质疏鬆症是一种会导致骨组织和强度退化的疾病。透过执行不同的扫描来诊断，例如 X 光、电脑断层扫描 (CT) 和磁振造影 (MRI)。目前有多种不同剂型的药物可供选择，从一般药片到静脉注射（IV）输液，用于缓解骨质疏鬆症的症状。这些药物有助于恢復吸收和形成的平衡，修復骨骼的微观缺陷，降低骨折风险并提高患者的整体肌肉力量。

由于久坐的生活方式、过量饮酒和烟草使用量的增加，骨质疏鬆症的盛行率不断上升，这是推动市场成长的关键因素。患有乳糜泻、肾臟或肝臟疾病、癌症、红斑性狼疮、多发性骨髓瘤和类风湿性关节炎的人数不断增加，进一步加速了市场的成长。此外，骨质流失随着年龄的增长而增加，这增加了老年人骨质疏鬆症的风险。因此，不断增长的老年人口正在对全球骨质疏鬆症药物的需求产生积极影响。此外，一些管理机构正在开发新的疗法，这有助于市场的成长。例如，美国食品药物管理局 (FDA) 已批准针对骨折风险高或对其他骨质疏鬆症治疗不耐受的停经后妇女使用新型骨质疏鬆症药物。除此之外，预计处于后期临床试验的多种药物将推动未来几年的市场成长。

本报告回答的关键问题

  • 全球骨质疏鬆药物市场有多大？
  • 2023-2028年全球骨质疏鬆药物市场的预期成长率为何？
  • 推动全球骨质疏鬆药物市场的关键因素是什么？
  • COVID-19 对全球骨质疏鬆症药物市场有何影响？
  • 根据产品类型，全球骨质疏鬆症药物市场的细分如何？
  • 根据给药途径，全球骨质疏鬆症药物市场的细分如何？
  • 全球骨质疏鬆药物市场的重点区域有哪些？
  • 全球骨质疏鬆症药物市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球骨质疏鬆药物市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：依产品类型分類的市场区隔

  • 双磷酸盐
    • 市场走向
    • 市场预测
  • 降钙素
    • 市场走向
    • 市场预测
  • Rank 配体抑制剂
    • 市场走向
    • 市场预测
  • 副甲状腺素治疗 (PTH)
    • 市场走向
    • 市场预测
  • 选择性雌激素受体调节剂 (SERM)
    • 市场走向
    • 市场预测
  • 硬化素抑制剂
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：按管理途径分類的市场

  • 口服
    • 市场走向
    • 市场预测
  • 可注射
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Amgen Inc.
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • GlaxoSmithKline Plc
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Radius Health Inc.
    • Teva Pharmaceutical Industries Ltd.
    • UCB SA
Product Code: SR112023A3104

Abstract

The global osteoporosis drugs market size reached US$ 15.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 21.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2022-2028.

Osteoporosis is a disease that causes deterioration of bone tissues and strength. It is diagnosed by performing different scans, such as X-ray, computed tomography (CT) and magnetic resonance imaging (MRI). Various drugs are currently available in different formulations, ranging from regular tablets to intravenous (IV) infusions, for alleviating the symptoms of osteoporosis. These drugs help restore the balance of resorption and formation, repair microscopic defects in bones, reduce the risk of fractures and improve the overall muscle strength of the patients.

The growing prevalence of osteoporosis on account of sedentary lifestyles, excessive consumption of alcohol, and rising utilization of tobacco represent the key factors bolstering the growth of the market. The increasing number of individuals who have celiac disease, kidney or liver disease, cancer, lupus, multiple myeloma and rheumatoid arthritis is further accelerating the market growth. Moreover, bone mass loss increases with age, which raises the risk of developing osteoporosis among older people. Consequently, the rising geriatric population is positively influencing the demand for osteoporosis drugs worldwide. Furthermore, several governing authorities are developing novel therapeutics, which is contributing to the market growth. For instance, the US Food and Drug Administration (FDA) has approved novel osteoporosis drugs for postmenopausal women who are at a high risk of fractures or are intolerant to other osteoporosis therapies. Besides this, a wide range of drugs in late-stage clinical trials is anticipated to propel the market growth in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global osteoporosis drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type and route of administration.

Breakup by Product Type:

Bisphosphonates

Calcitonin

Rank Ligand Inhibitor

Parathyroid Hormone Therapy (PTH)

Selective Estrogen Receptor Modulators (SERMs)

Sclerostin Inhibitor

Others

Breakup by Route of Administration:

Oral

Injectable

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Radius Health Inc., Teva Pharmaceutical Industries Ltd. and UCB S.A.

Key Questions Answered in This Report

  • 1. How big is the global osteoporosis drugs market?
  • 2. What is the expected growth rate of the global osteoporosis drugs market during 2023-2028?
  • 3. What are the key factors driving the global osteoporosis drugs market?
  • 4. What has been the impact of COVID-19 on the global osteoporosis drugs market?
  • 5. What is the breakup of the global osteoporosis drugs market based on the product type?
  • 6. What is the breakup of the global osteoporosis drugs market based on the route of administration?
  • 7. What are the key regions in the global osteoporosis drugs market?
  • 8. Who are the key players/companies in the global osteoporosis drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Osteoporosis Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Bisphosphonates
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Calcitonin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Rank Ligand Inhibitor
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Parathyroid Hormone Therapy (PTH)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Selective Estrogen Receptor Modulators (SERMs)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Sclerostin Inhibitor
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Injectable
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Amgen Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Eli Lilly and Company
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 F. Hoffmann-La Roche AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 GlaxoSmithKline Plc
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Merck & Co. Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Novartis AG
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Pfizer Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Radius Health Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
    • 13.3.9 Teva Pharmaceutical Industries Ltd.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 UCB S.A.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Osteoporosis Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Osteoporosis Drugs Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Osteoporosis Drugs Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Osteoporosis Drugs Market: Breakup by Route of Administration (in %), 2022
  • Figure 5: Global: Osteoporosis Drugs Market: Breakup by Region (in %), 2022
  • Figure 6: Global: Osteoporosis Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 7: Global: Osteoporosis Drugs (Bisphosphonates) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Osteoporosis Drugs (Bisphosphonates) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Osteoporosis Drugs (Calcitonin) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Osteoporosis Drugs (Calcitonin) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Osteoporosis Drugs (Rank Ligand Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Osteoporosis Drugs (Rank Ligand Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Osteoporosis Drugs (Parathyroid Hormone Therapy- PTH) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Osteoporosis Drugs (Parathyroid Hormone Therapy- PTH) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Osteoporosis Drugs (Selective Estrogen Receptor Modulators- SERMs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Osteoporosis Drugs (Selective Estrogen Receptor Modulators- SERMs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Osteoporosis Drugs (Sclerostin Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Osteoporosis Drugs (Sclerostin Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Osteoporosis Drugs (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Osteoporosis Drugs (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Osteoporosis Drugs (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Osteoporosis Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Osteoporosis Drugs (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Osteoporosis Drugs (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Osteoporosis Drugs (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Osteoporosis Drugs (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: North America: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: North America: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: United States: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: United States: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Canada: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Canada: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Asia-Pacific: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Asia-Pacific: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: China: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: China: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Japan: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Japan: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: India: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: India: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: South Korea: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: South Korea: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Australia: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Australia: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Indonesia: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Indonesia: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Others: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Others: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Europe: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Europe: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Germany: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Germany: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: France: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: France: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: United Kingdom: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: United Kingdom: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Italy: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Italy: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Spain: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Spain: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Russia: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Russia: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Latin America: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Latin America: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Brazil: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Brazil: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Mexico: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Mexico: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Middle East and Africa: Osteoporosis Drugs Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Middle East and Africa: Osteoporosis Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Middle East and Africa: Osteoporosis Drugs Market: Breakup by Country (in %), 2022
  • Figure 76: Global: Osteoporosis Drugs Industry: SWOT Analysis
  • Figure 77: Global: Osteoporosis Drugs Industry: Value Chain Analysis
  • Figure 78: Global: Osteoporosis Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Osteoporosis Drugs Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Osteoporosis Drugs Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Osteoporosis Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Osteoporosis Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Osteoporosis Drugs Market: Competitive Structure
  • Table 6: Global: Osteoporosis Drugs Market: Key Players